2011
DOI: 10.1007/s00044-011-9688-z
| |Summarize |Cite
|
Sign up to set email alerts

Synthesis, evaluation of 6,8-dibromo-2-aryl-2,3-dihydroquinolin-4(1H)-ones in MCF-7 (breast cancer) cell lines and their docking studies

Abstract: A series of novel 6,8-dibromo-2-aryl-2,3-dihydroquinolin-4(1H)-ones have been synthesized and evaluated in vitro (in MCF-7 breast cancer cell lines). Compounds 5a, 5d, 5e, and 5g exhibited potent GI 50 and TGI values compared with reference standard and compounds 5b and 5c showed moderate activity. The docking studies (in silico) were conducted to recognize the hypothetical binding motif of the title compounds within the active site of aromatase enzyme employing GOLD docking software. The binding mode and SAR … Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
15
2
1
0

Citation Types

1
12
0
0

Year Published

Range
2012
2012
2025
2025

Publication Types

Select...
17
1

Relationship

0
18

Authors

Journals

Cited by 18 publications

(13 citation statements)

References 22 publications

1
12
0
0
Order By: Relevance
How the paper below cites the one you are viewing
“…amounts through dietary sources and food supplements (more recently termed 'nutraceuticals'). It has been demonstrated that several flavanoid derivatives are potent AIs as well as effective antiproliferative agents against MCF-7 (breast cancer) cell lines (12,13). This substantiates our hypothesis that the flavonoid scaffold could churn out to be a milestone in developing the next generation of safer AIs.…”
supporting
confidence: 85%